Ionis and Otsuka secure EU approval for HAE therapy DAWNZERA
Ionis Pharmaceuticals (NASDAQ:IONS) and Otsuka Pharmaceutical achieved a major regulatory victory Wednesday as the European Commission (EC) granted marketing authorization for DAWNZERA (donidalorsen).











